Profound impact in many clinical fields
The clinical fields of cardiac imaging, oncology, and pulmonology all have their own unique demands of medical images. In cardiac imaging, it is capturing the heart while moving, which therefore requires speed. Naeotom Alpha delivers speed thanks to its Dual Source design and benefits from spectral information and high resolution for removing obstructions caused by calcifications. This enables diagnostic assessment and allows more patients to benefit from CT imaging –even those with a high calcium burden.
The high precision offered by Naeotom Alpha is also highly beneficial in oncology, where reliable and consistent evaluation of disease progress is the most important factor.

Ad Statistics
Times Displayed: 21862
Times Visited: 433 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Therefore, clinical images need to be as conclusive and consistent as possible to make the right decisions. In pulmonology, images need to contain all meaningful answers in as few scans as possible to avoid delays in treatment and potentially severe consequences for patients. These needs are met and often exceeded by Naeotom Alpha’s features. Its clinical images inherently carry more information than ever possible before for precise diagnosis, follow-up, and treatment.
Expanding the leading role of CT imaging in clinical decision-making
The implications of this innovation from Siemens Healthineers are far reaching for patients and physicians and may profoundly change the way that CT imaging is performed: It adds clinical value for fast and reliable diagnoses by the physician by improving image quality, potentially leading to less uncertainty for physicians and patients. The new technology helps in almost every clinical field, but especially when fine structures have to be evaluated.
In over 15 years of research into photon-counting CT imaging, Siemens Healthineers has filed over 500 patents related to this technology and collaborated closely with clinical partners to test and validate the clinical capabilities and use cases. Six prototypes have been evaluated and improved on over the years. With a rotation speed of 250 milliseconds and two X-ray tubes and detectors (Dual Source), Naeotom Alpha is not only the first photon-counting CT system on the market but is also a very powerful, fast, and precise CT scanner.
Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies are continuously developing their product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care. In fiscal 2022, which ended on September 30, 2022, Siemens Healthineers, which has approximately 69,500 employees worldwide, generated revenue of around €21.7 billion and adjusted EBIT of almost €3.7 billion. Further information is available at www.siemens-healthineers.com.
Back to HCB News